Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.33 AUD | -2.26% | -1.81% | -10.17% |
30/04 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
17/04 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Electrical Components & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.17% | 30Cr | - | ||
+6.42% | 940.56Cr | B | ||
+20.79% | 771.27Cr | C | ||
+8.82% | 132.72Cr | - | - | |
+74.72% | 74Cr | - | - | |
+80.56% | 66Cr | - | ||
-7.81% | 66Cr | - | - | |
+237.60% | 70Cr | - | - | |
-3.05% | 60Cr | - | - | |
+16.18% | 45Cr | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- IPG Stock
- Ratings IPD Group Limited